|
|
|
@ -35,7 +35,7 @@
|
|
|
|
% TITLE PAGE
|
|
|
|
% TITLE PAGE
|
|
|
|
%----------------------------------------------------------------------------------------
|
|
|
|
%----------------------------------------------------------------------------------------
|
|
|
|
|
|
|
|
|
|
|
|
\title[short title]{Long title}
|
|
|
|
\title[Clinical Trials]{Pharmaceutial competitors and their effect on clinical trial completion}
|
|
|
|
|
|
|
|
|
|
|
|
\author{Will King} % Your name
|
|
|
|
\author{Will King} % Your name
|
|
|
|
\institute[WSU] % Your institution as it will appear on the bottom of every slide, may be shorthand to save space
|
|
|
|
\institute[WSU] % Your institution as it will appear on the bottom of every slide, may be shorthand to save space
|
|
|
|
@ -56,47 +56,274 @@ Washington State University \\ % Your institution for the title page
|
|
|
|
\end{frame}
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
\begin{frame}
|
|
|
|
|
|
|
|
\frametitle{Introduction}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
\begin{frame}[allowframebreaks] %Allow frame breaks
|
|
|
|
\begin{frame}[allowframebreaks] %Allow frame breaks
|
|
|
|
\frametitle{Overview} % Table of contents slide, comment this out to remove it
|
|
|
|
\frametitle{Overview} % Table of contents slide, comment this out to remove it
|
|
|
|
\tableofcontents
|
|
|
|
\tableofcontents
|
|
|
|
\end{frame}
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
|
|
|
|
%-------------------------------------------------------------------------------------
|
|
|
|
%-------------------------------------------------------------------------------------
|
|
|
|
%%%%%%%%%%%%%%%%%%%% Developing the Model%%%%%%%%%%%%%%%%%%%%%%%%
|
|
|
|
%%%%%%%%%%%%%%%%%%%% Introduction and Background %%%%%%%%%%%%%%%%%%%%%%%%
|
|
|
|
\section{Money: Supply and Demand}
|
|
|
|
\section{Background}
|
|
|
|
|
|
|
|
% TOC
|
|
|
|
|
|
|
|
% - Background on drug process
|
|
|
|
|
|
|
|
% - Literature on clinical trials
|
|
|
|
|
|
|
|
% - My questions
|
|
|
|
%-------------------------------------------------------------------------------------
|
|
|
|
%-------------------------------------------------------------------------------------
|
|
|
|
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
%-------------------------------
|
|
|
|
\begin{frame}
|
|
|
|
\begin{frame}
|
|
|
|
\frametitle{What is Money?}
|
|
|
|
\frametitle{Clinical Trials and Drug develoment}
|
|
|
|
\begin{block}{Money}
|
|
|
|
% add info about trials
|
|
|
|
A commodity that is:
|
|
|
|
% - Requirements (pre registered design [2007], updated "regularly" on clinicaltrials.gov)
|
|
|
|
|
|
|
|
% - Phases (1,2,3,4, mixed)
|
|
|
|
|
|
|
|
% - Safety and Ethicas (oversight boards, restrictions on payments)
|
|
|
|
|
|
|
|
% - Approval processes (biologics vs small-molecule)
|
|
|
|
|
|
|
|
% add info about drugs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The FDA requires clinical trials before approving new drug compounds
|
|
|
|
|
|
|
|
\begin{itemize}
|
|
|
|
|
|
|
|
\item Pre-registered design
|
|
|
|
|
|
|
|
\item Updated regularly on clinicaltrials.gov
|
|
|
|
|
|
|
|
\item Often requires an oversight board.
|
|
|
|
|
|
|
|
\item Goal is to prove efficacy and safety of a compound/dosage/route.
|
|
|
|
|
|
|
|
\item A new drug candidate (NDC) must complete 3 phases of clinical trials before approval.
|
|
|
|
|
|
|
|
\item Phases are reviewed with FDA.
|
|
|
|
|
|
|
|
\item Not all clinical trials are for new drugs.
|
|
|
|
|
|
|
|
\end{itemize}
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%-----------------------------
|
|
|
|
|
|
|
|
\begin{frame}
|
|
|
|
|
|
|
|
\frametitle{Literature}
|
|
|
|
\begin{itemize}
|
|
|
|
\begin{itemize}
|
|
|
|
\item Medium of exchange: A generally accepted means of payment.
|
|
|
|
\item Ekaterina
|
|
|
|
\item Store of value: A method to transfer value from now into the future.
|
|
|
|
\item Adams
|
|
|
|
|
|
|
|
\item
|
|
|
|
\end{itemize}
|
|
|
|
\end{itemize}
|
|
|
|
\end{block}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
What types of money exist?
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%-----------------------------
|
|
|
|
|
|
|
|
\begin{frame}
|
|
|
|
|
|
|
|
\frametitle{Questions of Interest}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
\begin{itemize}
|
|
|
|
|
|
|
|
\item How do the competitors on the market affect clinical trial completion?
|
|
|
|
|
|
|
|
\item How is this effect moderated by the enrollment of participants?
|
|
|
|
|
|
|
|
\end{itemize}
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
\begin{frame}
|
|
|
|
|
|
|
|
\frametitle{Audience Questions}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
\center{What can I clarify?}
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
%-------------------------------------------------------------------------------------
|
|
|
|
|
|
|
|
%%%%%%%%%%%%%%%%%%%% Causality and Data %%%%%%%%%%%%%%%%%%%%%%%%
|
|
|
|
|
|
|
|
\section{Causal Story and Data}
|
|
|
|
|
|
|
|
% TOC
|
|
|
|
|
|
|
|
% - Causal Story (no subsection)
|
|
|
|
|
|
|
|
% - Clinical trials: targets specific drug/condition combination.
|
|
|
|
|
|
|
|
% - Enrollment process: patients counsel with providers
|
|
|
|
|
|
|
|
% - Trials terminate if unsafe, ineffective, unprofitable, or cannot enroll patients
|
|
|
|
|
|
|
|
% - Ethical concerns exist throughout.
|
|
|
|
|
|
|
|
% - This is complicated by the fact that the experiment reveals information over time.
|
|
|
|
|
|
|
|
% - Formalization
|
|
|
|
|
|
|
|
% - Data Sources
|
|
|
|
|
|
|
|
%-------------------------------------------------------------------------------------
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
\begin{frame}[shrink=10] %evil option is helpful here.
|
|
|
|
|
|
|
|
\frametitle{How do clinical trials proceed?}
|
|
|
|
|
|
|
|
\begin{columns}[T]
|
|
|
|
|
|
|
|
\begin{column}{0.5\textwidth}
|
|
|
|
|
|
|
|
What does a complete trial look like.
|
|
|
|
|
|
|
|
\begin{enumerate}
|
|
|
|
|
|
|
|
\item Study sponsor comes up with design
|
|
|
|
|
|
|
|
\item Apply for NCT ID from ClinicalTrials.gov
|
|
|
|
|
|
|
|
\item Begin enrolling participants
|
|
|
|
|
|
|
|
\item Update ClinicalTrials.gov to recruit
|
|
|
|
|
|
|
|
\item Close Enrollment
|
|
|
|
|
|
|
|
\item Update ClinicalTrials.gov as not recruiting*
|
|
|
|
|
|
|
|
\item Reach primary objectives
|
|
|
|
|
|
|
|
\item Update ClinicalTrials.gov as complete
|
|
|
|
|
|
|
|
\item Reach secondary objectives
|
|
|
|
|
|
|
|
\item Update ClinicalTrials.gov with more information
|
|
|
|
|
|
|
|
\end{enumerate}
|
|
|
|
|
|
|
|
\end{column}
|
|
|
|
|
|
|
|
\begin{column}{0.5\textwidth}
|
|
|
|
|
|
|
|
What does an incomplete trial look like?
|
|
|
|
|
|
|
|
\begin{enumerate}
|
|
|
|
|
|
|
|
\item Study sponsor comes up with design
|
|
|
|
|
|
|
|
\item Apply for NCT ID from ClinicalTrials.gov
|
|
|
|
|
|
|
|
\item Begin enrolling participants
|
|
|
|
|
|
|
|
\item Update ClinicalTrials.gov to advertise
|
|
|
|
|
|
|
|
\item Run into issues:
|
|
|
|
\begin{itemize}
|
|
|
|
\begin{itemize}
|
|
|
|
\item M0: Currency
|
|
|
|
\item Safety
|
|
|
|
\item \textbf{M1: M0 + Checking/bank deposits}
|
|
|
|
\item Efficacy
|
|
|
|
|
|
|
|
\item Profitability
|
|
|
|
|
|
|
|
\item Feasiblity (enrollment, PI leaves, etc.)
|
|
|
|
\end{itemize}
|
|
|
|
\end{itemize}
|
|
|
|
|
|
|
|
\item Close Enrollment*
|
|
|
|
|
|
|
|
\item Decide to terminate clinical trial.
|
|
|
|
|
|
|
|
\item Update ClinicalTrials.gov as terminated.
|
|
|
|
|
|
|
|
\end{enumerate}
|
|
|
|
|
|
|
|
\end{column}
|
|
|
|
|
|
|
|
\end{columns}
|
|
|
|
\end{frame}
|
|
|
|
\end{frame}
|
|
|
|
%-------------------------------
|
|
|
|
%-------------------------------
|
|
|
|
\begin{frame}
|
|
|
|
\begin{frame}
|
|
|
|
\frametitle{Money Demand}
|
|
|
|
\frametitle{ClinicalTrials.gov}
|
|
|
|
|
|
|
|
Thus ClinicalTrials.gov becomes an (append only) repository of
|
|
|
|
|
|
|
|
the ``current'' status of clincal trials.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominal Money Demand
|
|
|
|
As it is designed to help faciltate enrollment in clinical trials,
|
|
|
|
\begin{align}
|
|
|
|
the record includes important information such as
|
|
|
|
M^d = P \cdot L(R,Y)
|
|
|
|
|
|
|
|
\end{align}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
\begin{itemize}
|
|
|
|
\begin{itemize}
|
|
|
|
\item $Y \uparrow \Rightarrow L(R,Y) \uparrow$
|
|
|
|
\item drugs
|
|
|
|
\item $R \downarrow \Rightarrow L(R,Y) \uparrow$
|
|
|
|
\item study arms
|
|
|
|
|
|
|
|
\item conditions
|
|
|
|
|
|
|
|
\item expected and final enrollment figures
|
|
|
|
|
|
|
|
\item current status
|
|
|
|
\end{itemize}
|
|
|
|
\end{itemize}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ClinicalTrials.gov also reports the ``history'' from previous
|
|
|
|
|
|
|
|
updates.
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
\begin{frame}
|
|
|
|
|
|
|
|
\frametitle{Questions?}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
%--------------------------------
|
|
|
|
|
|
|
|
%%%%%%%%%%%%%%%%%%%% Causal Formalization
|
|
|
|
|
|
|
|
\subsection{Formalization}
|
|
|
|
|
|
|
|
% - Introduce basic triangle
|
|
|
|
|
|
|
|
% - discuss total vs direct effects
|
|
|
|
|
|
|
|
% -
|
|
|
|
|
|
|
|
% - Add confounders and controls
|
|
|
|
|
|
|
|
% - Introduce backdoor criterion
|
|
|
|
|
|
|
|
%--------------------------------
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
\begin{frame}
|
|
|
|
|
|
|
|
\frametitle{Questions?}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
%--------------------------------
|
|
|
|
|
|
|
|
%%%%%%%%%%%%%%%%%%%% Data sources
|
|
|
|
|
|
|
|
\subsection{Data Sources}
|
|
|
|
|
|
|
|
% TOC
|
|
|
|
|
|
|
|
% - Main Data Sources
|
|
|
|
|
|
|
|
% - ClinicalTrials.gov and AACT
|
|
|
|
|
|
|
|
% - IHME Burden of Disease
|
|
|
|
|
|
|
|
% - Marketing Data
|
|
|
|
|
|
|
|
% - MeSH, RxNorm/RxNav
|
|
|
|
|
|
|
|
% - How did I Link Data Sources
|
|
|
|
|
|
|
|
% - Data Sizes
|
|
|
|
|
|
|
|
%--------------------------------
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
\begin{frame}
|
|
|
|
|
|
|
|
\frametitle{Questions?}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
%-------------------------------------------------------------------------------------
|
|
|
|
|
|
|
|
%%%%%%%%%%%%%%%%%%%% Analysis %%%%%%%%%%%%%%%%%%%%%%%%
|
|
|
|
|
|
|
|
\section{Analysis}
|
|
|
|
|
|
|
|
% TOC
|
|
|
|
|
|
|
|
% - Review questions and datasets to use for each
|
|
|
|
|
|
|
|
% -
|
|
|
|
|
|
|
|
% -
|
|
|
|
|
|
|
|
%-------------------------------------------------------------------------------------
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
\begin{frame}
|
|
|
|
|
|
|
|
\frametitle{Questions?}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%--------------------------------
|
|
|
|
|
|
|
|
%%%%%%%%%%%%%%%%%%%% Econometric Model
|
|
|
|
|
|
|
|
\subsection{Econometric Model}
|
|
|
|
|
|
|
|
% - Present model per effect
|
|
|
|
|
|
|
|
% -
|
|
|
|
|
|
|
|
% -
|
|
|
|
|
|
|
|
%--------------------------------
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
\begin{frame}
|
|
|
|
|
|
|
|
\frametitle{Questions?}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%--------------------------------
|
|
|
|
|
|
|
|
%%%%%%%%%%%%%%%%%%%% Results
|
|
|
|
|
|
|
|
\subsection{Results}
|
|
|
|
|
|
|
|
%--------------------------------
|
|
|
|
|
|
|
|
%--------------------------------
|
|
|
|
|
|
|
|
\subsubsection{Total Effect}
|
|
|
|
|
|
|
|
% - Review Parameter Values
|
|
|
|
|
|
|
|
% - hyperparameters
|
|
|
|
|
|
|
|
% - Table of MLE
|
|
|
|
|
|
|
|
% - Distributions
|
|
|
|
|
|
|
|
% - betas
|
|
|
|
|
|
|
|
% - Table of MLE
|
|
|
|
|
|
|
|
% - Distributions
|
|
|
|
|
|
|
|
% - Review Posterior Prediction for interventions
|
|
|
|
|
|
|
|
%--------------------------------
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
\begin{frame}
|
|
|
|
|
|
|
|
\frametitle{Questions?}
|
|
|
|
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
%--------------------------------
|
|
|
|
|
|
|
|
\subsubsection{Direct Effects}
|
|
|
|
|
|
|
|
% - Review Parameter Values
|
|
|
|
|
|
|
|
% - hyperparameters
|
|
|
|
|
|
|
|
% - Table of MLE
|
|
|
|
|
|
|
|
% - Distributions
|
|
|
|
|
|
|
|
% - betas
|
|
|
|
|
|
|
|
% - Table of MLE
|
|
|
|
|
|
|
|
% - Distributions
|
|
|
|
|
|
|
|
% - Review Posterior Prediction for interventions
|
|
|
|
|
|
|
|
%--------------------------------
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
\begin{frame}
|
|
|
|
|
|
|
|
\frametitle{Questions?}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
%-------------------------------------------------------------------------------------
|
|
|
|
|
|
|
|
%%%%%%%%%%%%%%%%%%%% Conclusion %%%%%%%%%%%%%%%%%%%%%%%%
|
|
|
|
|
|
|
|
\section{Conclusion}
|
|
|
|
|
|
|
|
%-------------------------------------------------------------------------------------
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
\begin{frame}
|
|
|
|
|
|
|
|
\frametitle{Final Questions}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
\center{\huge{Time is yours to ask any remaining questions.}}
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%-------------------------------------------------------------------------------------
|
|
|
|
|
|
|
|
%%%%%%%%%%%%%%%%%%%% Appendicies %%%%%%%%%%%%%%%%%%%%%%%%
|
|
|
|
|
|
|
|
\section{Appendices}
|
|
|
|
|
|
|
|
%-------------------------------------------------------------------------------------
|
|
|
|
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
%-------------------------------
|
|
|
|
\begin{frame}
|
|
|
|
\begin{frame}
|
|
|
|
\frametitle{Equilibrium in the Money Market}
|
|
|
|
\frametitle{Equilibrium in the Money Market}
|
|
|
|
@ -111,11 +338,6 @@ Washington State University \\ % Your institution for the title page
|
|
|
|
\end{figure}
|
|
|
|
\end{figure}
|
|
|
|
\end{frame}
|
|
|
|
\end{frame}
|
|
|
|
%-------------------------------
|
|
|
|
%-------------------------------
|
|
|
|
\begin{frame}
|
|
|
|
|
|
|
|
\frametitle{Questions?}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
\end{frame}
|
|
|
|
|
|
|
|
%-------------------------------
|
|
|
|
|
|
|
|
\end{document}
|
|
|
|
\end{document}
|
|
|
|
%=========================================
|
|
|
|
%=========================================
|
|
|
|
%\begin{frame}
|
|
|
|
%\begin{frame}
|
|
|
|
|